MAOI’s: concomitant use contraindicated. Avoid MAOI’s 14 days before starting venlafaxine and 7 days after stopping venlafaxine.
Cimetidine: Caution in patients with pre-existing hypertension, in elderly patients and patients with hepatic dysfunction.
VENLAFAXINE EXTENDED RELEASE 37.5MG TABLET
The following summary does not encompass all the essential details for the proper and safe utilization of VENLAFAXINE EXTENDED RELEASE 37.5MG TABLET. For a comprehensive understanding, please refer to the complete prescribing information for VENLAFAXINE EXTENDED RELEASE 37.5MG TABLET.
Venlafaxine Hydrochloride Extended Release Tablets are formulated for oral administration. These tablets release venlafaxine in a controlled manner over an extended period.
1- Major Depressive Disorder
2- Social Anxiety Disorder
Starting Dose :
1- 75 mg/day (in some patients, 37.5 mg/day for 4-7 days)
2- 75 mg/day
Dose Increase :
1- 75 mg/day increments at intervals of 4 days or longer
2- No benefit at higher doses
Maximum Dose :
1- 225 mg/day
2- 75 mg/day
